Reprogrammed iPS cells could be used to create Type 1 diabetes models

09/1/2009 | MIT Technology Review

U.S. researchers said they were able to turn ordinary adult cells extracted from patients with Type 1 diabetes into induced pluripotent stem cells, which can be turned into tissues that resemble pancreatic beta cells. They think the resulting iPS cells could be used to create disease models that would allow scientists to study the development of Type 1 diabetes and possibly discover new treatments for the disease.

View Full Article in:

MIT Technology Review

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT